1. Statin (3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitor)-based therapy for hepatitis C virus (HCV) infection-related diseases in the era of direct-acting antiviral agents
   Sara Sobhy Kishta et al, 2016, F1000Research CrossRef
2. Statin (3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitor)-based therapy for hepatitis C virus (HCV) infection-related diseases in the era of direct-acting antiviral agents
   Sara Sobhy Kishta et al, 2017, F1000Research CrossRef
3. Statin Treatment as a Targeted Therapy for APC-Mutated Colorectal Cancer
   Hannah Shailes et al, 2022, Frontiers in Oncology CrossRef
4. Statin (3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitor)-based therapy for hepatitis C virus (HCV) infection-related diseases in the era of direct-acting antiviral agents
   Sara Sobhy Kishta et al, 2016, F1000Research CrossRef